Report Overview
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
The global Gastrointestinal OTC Drugs market size was estimated at USD 5900.70 million in 2023 and is projected to reach USD 9472.60 million by 2032, exhibiting a CAGR of 5.40% during the forecast period.
North America Gastrointestinal OTC Drugs market size was estimated at USD 1683.18 million in 2023, at a CAGR of 4.63% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Gastrointestinal OTC Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal OTC Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal OTC Drugs market in any manner.
Global Gastrointestinal OTC Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Market Segmentation (by Type)
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Gastrointestinal OTC Drugs Market
� Overview of the regional outlook of the Gastrointestinal OTC Drugs Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal OTC Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal OTC Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gastrointestinal OTC Drugs
1.2 Key Market Segments
1.2.1 Gastrointestinal OTC Drugs Segment by Type
1.2.2 Gastrointestinal OTC Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gastrointestinal OTC Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Gastrointestinal OTC Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gastrointestinal OTC Drugs Market Competitive Landscape
3.1 Global Gastrointestinal OTC Drugs Sales by Manufacturers (2019-2025)
3.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2019-2025)
3.3 Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Gastrointestinal OTC Drugs Sales Sites, Area Served, Product Type
3.6 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
3.6.1 Gastrointestinal OTC Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal OTC Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gastrointestinal OTC Drugs Industry Chain Analysis
4.1 Gastrointestinal OTC Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gastrointestinal OTC Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gastrointestinal OTC Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2019-2025)
6.3 Global Gastrointestinal OTC Drugs Market Size Market Share by Type (2019-2025)
6.4 Global Gastrointestinal OTC Drugs Price by Type (2019-2025)
7 Gastrointestinal OTC Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal OTC Drugs Market Sales by Application (2019-2025)
7.3 Global Gastrointestinal OTC Drugs Market Size (M USD) by Application (2019-2025)
7.4 Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2019-2025)
8 Gastrointestinal OTC Drugs Market Consumption by Region
8.1 Global Gastrointestinal OTC Drugs Sales by Region
8.1.1 Global Gastrointestinal OTC Drugs Sales by Region
8.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal OTC Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal OTC Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal OTC Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Gastrointestinal OTC Drugs Market Production by Region
9.1 Global Production of Gastrointestinal OTC Drugs by Region (2019-2025)
9.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2019-2025)
9.3 Global Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Gastrointestinal OTC Drugs Production
9.4.1 North America Gastrointestinal OTC Drugs Production Growth Rate (2019-2025)
9.4.2 North America Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Gastrointestinal OTC Drugs Production
9.5.1 Europe Gastrointestinal OTC Drugs Production Growth Rate (2019-2025)
9.5.2 Europe Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Gastrointestinal OTC Drugs Production (2019-2025)
9.6.1 Japan Gastrointestinal OTC Drugs Production Growth Rate (2019-2025)
9.6.2 Japan Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Gastrointestinal OTC Drugs Production (2019-2025)
9.7.1 China Gastrointestinal OTC Drugs Production Growth Rate (2019-2025)
9.7.2 China Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Gastrointestinal OTC Drugs Basic Information
10.1.2 GlaxoSmithKline Gastrointestinal OTC Drugs Product Overview
10.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline Gastrointestinal OTC Drugs SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 Pfizer
10.2.1 Pfizer Gastrointestinal OTC Drugs Basic Information
10.2.2 Pfizer Gastrointestinal OTC Drugs Product Overview
10.2.3 Pfizer Gastrointestinal OTC Drugs Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer Gastrointestinal OTC Drugs SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Gastrointestinal OTC Drugs Basic Information
10.3.2 Johnson and Johnson Gastrointestinal OTC Drugs Product Overview
10.3.3 Johnson and Johnson Gastrointestinal OTC Drugs Product Market Performance
10.3.4 Johnson and Johnson Gastrointestinal OTC Drugs SWOT Analysis
10.3.5 Johnson and Johnson Business Overview
10.3.6 Johnson and Johnson Recent Developments
10.4 Bayer
10.4.1 Bayer Gastrointestinal OTC Drugs Basic Information
10.4.2 Bayer Gastrointestinal OTC Drugs Product Overview
10.4.3 Bayer Gastrointestinal OTC Drugs Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Procter and Gamble
10.5.1 Procter and Gamble Gastrointestinal OTC Drugs Basic Information
10.5.2 Procter and Gamble Gastrointestinal OTC Drugs Product Overview
10.5.3 Procter and Gamble Gastrointestinal OTC Drugs Product Market Performance
10.5.4 Procter and Gamble Business Overview
10.5.5 Procter and Gamble Recent Developments
10.6 Perrigo
10.6.1 Perrigo Gastrointestinal OTC Drugs Basic Information
10.6.2 Perrigo Gastrointestinal OTC Drugs Product Overview
10.6.3 Perrigo Gastrointestinal OTC Drugs Product Market Performance
10.6.4 Perrigo Business Overview
10.6.5 Perrigo Recent Developments
10.7 Abbott
10.7.1 Abbott Gastrointestinal OTC Drugs Basic Information
10.7.2 Abbott Gastrointestinal OTC Drugs Product Overview
10.7.3 Abbott Gastrointestinal OTC Drugs Product Market Performance
10.7.4 Abbott Business Overview
10.7.5 Abbott Recent Developments
10.8 Sanofi
10.8.1 Sanofi Gastrointestinal OTC Drugs Basic Information
10.8.2 Sanofi Gastrointestinal OTC Drugs Product Overview
10.8.3 Sanofi Gastrointestinal OTC Drugs Product Market Performance
10.8.4 Sanofi Business Overview
10.8.5 Sanofi Recent Developments
10.9 Teva Pharmaceutical
10.9.1 Teva Pharmaceutical Gastrointestinal OTC Drugs Basic Information
10.9.2 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Overview
10.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Market Performance
10.9.4 Teva Pharmaceutical Business Overview
10.9.5 Teva Pharmaceutical Recent Developments
10.10 Nestle
10.10.1 Nestle Gastrointestinal OTC Drugs Basic Information
10.10.2 Nestle Gastrointestinal OTC Drugs Product Overview
10.10.3 Nestle Gastrointestinal OTC Drugs Product Market Performance
10.10.4 Nestle Business Overview
10.10.5 Nestle Recent Developments
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Gastrointestinal OTC Drugs Basic Information
10.11.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Overview
10.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Market Performance
10.11.4 Boehringer Ingelheim Business Overview
10.11.5 Boehringer Ingelheim Recent Developments
10.12 Reckitt Benckiser
10.12.1 Reckitt Benckiser Gastrointestinal OTC Drugs Basic Information
10.12.2 Reckitt Benckiser Gastrointestinal OTC Drugs Product Overview
10.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Product Market Performance
10.12.4 Reckitt Benckiser Business Overview
10.12.5 Reckitt Benckiser Recent Developments
10.13 Purdue Pharma
10.13.1 Purdue Pharma Gastrointestinal OTC Drugs Basic Information
10.13.2 Purdue Pharma Gastrointestinal OTC Drugs Product Overview
10.13.3 Purdue Pharma Gastrointestinal OTC Drugs Product Market Performance
10.13.4 Purdue Pharma Business Overview
10.13.5 Purdue Pharma Recent Developments
11 Gastrointestinal OTC Drugs Market Forecast by Region
11.1 Global Gastrointestinal OTC Drugs Market Size Forecast
11.2 Global Gastrointestinal OTC Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal OTC Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast by Region
11.2.4 South America Gastrointestinal OTC Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal OTC Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Gastrointestinal OTC Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Type (2025-2032)
12.1.2 Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Gastrointestinal OTC Drugs by Type (2025-2032)
12.2 Global Gastrointestinal OTC Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Gastrointestinal OTC Drugs Sales (K MT) Forecast by Application
12.2.2 Global Gastrointestinal OTC Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal OTC Drugs Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal OTC Drugs Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Gastrointestinal OTC Drugs Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2022)
Table 10. Global Market Gastrointestinal OTC Drugs Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Gastrointestinal OTC Drugs Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal OTC Drugs Product Type
Table 13. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal OTC Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal OTC Drugs Market Challenges
Table 22. Global Gastrointestinal OTC Drugs Sales by Type (K MT)
Table 23. Global Gastrointestinal OTC Drugs Market Size by Type (M USD)
Table 24. Global Gastrointestinal OTC Drugs Sales (K MT) by Type (2019-2025)
Table 25. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2019-2025)
Table 26. Global Gastrointestinal OTC Drugs Market Size (M USD) by Type (2019-2025)
Table 27. Global Gastrointestinal OTC Drugs Market Size Share by Type (2019-2025)
Table 28. Global Gastrointestinal OTC Drugs Price (USD/MT) by Type (2019-2025)
Table 29. Global Gastrointestinal OTC Drugs Sales (K MT) by Application
Table 30. Global Gastrointestinal OTC Drugs Market Size by Application
Table 31. Global Gastrointestinal OTC Drugs Sales by Application (2019-2025) & (K MT)
Table 32. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2019-2025)
Table 33. Global Gastrointestinal OTC Drugs Sales by Application (2019-2025) & (M USD)
Table 34. Global Gastrointestinal OTC Drugs Market Share by Application (2019-2025)
Table 35. Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2019-2025)
Table 36. Global Gastrointestinal OTC Drugs Sales by Region (2019-2025) & (K MT)
Table 37. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2019-2025)
Table 38. North America Gastrointestinal OTC Drugs Sales by Country (2019-2025) & (K MT)
Table 39. Europe Gastrointestinal OTC Drugs Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2019-2025) & (K MT)
Table 41. South America Gastrointestinal OTC Drugs Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Gastrointestinal OTC Drugs Sales by Region (2019-2025) & (K MT)
Table 43. Global Gastrointestinal OTC Drugs Production (K MT) by Region (2019-2025)
Table 44. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2019-2025)
Table 46. Global Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. GlaxoSmithKline Gastrointestinal OTC Drugs Basic Information
Table 52. GlaxoSmithKline Gastrointestinal OTC Drugs Product Overview
Table 53. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. GlaxoSmithKline Business Overview
Table 55. GlaxoSmithKline Gastrointestinal OTC Drugs SWOT Analysis
Table 56. GlaxoSmithKline Recent Developments
Table 57. Pfizer Gastrointestinal OTC Drugs Basic Information
Table 58. Pfizer Gastrointestinal OTC Drugs Product Overview
Table 59. Pfizer Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Pfizer Business Overview
Table 61. Pfizer Gastrointestinal OTC Drugs SWOT Analysis
Table 62. Pfizer Recent Developments
Table 63. Johnson and Johnson Gastrointestinal OTC Drugs Basic Information
Table 64. Johnson and Johnson Gastrointestinal OTC Drugs Product Overview
Table 65. Johnson and Johnson Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Johnson and Johnson Gastrointestinal OTC Drugs SWOT Analysis
Table 67. Johnson and Johnson Business Overview
Table 68. Johnson and Johnson Recent Developments
Table 69. Bayer Gastrointestinal OTC Drugs Basic Information
Table 70. Bayer Gastrointestinal OTC Drugs Product Overview
Table 71. Bayer Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Bayer Business Overview
Table 73. Bayer Recent Developments
Table 74. Procter and Gamble Gastrointestinal OTC Drugs Basic Information
Table 75. Procter and Gamble Gastrointestinal OTC Drugs Product Overview
Table 76. Procter and Gamble Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Procter and Gamble Business Overview
Table 78. Procter and Gamble Recent Developments
Table 79. Perrigo Gastrointestinal OTC Drugs Basic Information
Table 80. Perrigo Gastrointestinal OTC Drugs Product Overview
Table 81. Perrigo Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Perrigo Business Overview
Table 83. Perrigo Recent Developments
Table 84. Abbott Gastrointestinal OTC Drugs Basic Information
Table 85. Abbott Gastrointestinal OTC Drugs Product Overview
Table 86. Abbott Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Abbott Business Overview
Table 88. Abbott Recent Developments
Table 89. Sanofi Gastrointestinal OTC Drugs Basic Information
Table 90. Sanofi Gastrointestinal OTC Drugs Product Overview
Table 91. Sanofi Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Sanofi Business Overview
Table 93. Sanofi Recent Developments
Table 94. Teva Pharmaceutical Gastrointestinal OTC Drugs Basic Information
Table 95. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Overview
Table 96. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Recent Developments
Table 99. Nestle Gastrointestinal OTC Drugs Basic Information
Table 100. Nestle Gastrointestinal OTC Drugs Product Overview
Table 101. Nestle Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Nestle Business Overview
Table 103. Nestle Recent Developments
Table 104. Boehringer Ingelheim Gastrointestinal OTC Drugs Basic Information
Table 105. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Overview
Table 106. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Boehringer Ingelheim Business Overview
Table 108. Boehringer Ingelheim Recent Developments
Table 109. Reckitt Benckiser Gastrointestinal OTC Drugs Basic Information
Table 110. Reckitt Benckiser Gastrointestinal OTC Drugs Product Overview
Table 111. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Reckitt Benckiser Business Overview
Table 113. Reckitt Benckiser Recent Developments
Table 114. Purdue Pharma Gastrointestinal OTC Drugs Basic Information
Table 115. Purdue Pharma Gastrointestinal OTC Drugs Product Overview
Table 116. Purdue Pharma Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Purdue Pharma Business Overview
Table 118. Purdue Pharma Recent Developments
Table 119. Global Gastrointestinal OTC Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 120. Global Gastrointestinal OTC Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Gastrointestinal OTC Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 122. North America Gastrointestinal OTC Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Gastrointestinal OTC Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 124. Europe Gastrointestinal OTC Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Gastrointestinal OTC Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 126. Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Gastrointestinal OTC Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 128. South America Gastrointestinal OTC Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Gastrointestinal OTC Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Gastrointestinal OTC Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 132. Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Gastrointestinal OTC Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 134. Global Gastrointestinal OTC Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 135. Global Gastrointestinal OTC Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Gastrointestinal OTC Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal OTC Drugs Market Size (M USD), 2019-2032
Figure 5. Global Gastrointestinal OTC Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Gastrointestinal OTC Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal OTC Drugs Market Size by Country (M USD)
Figure 11. Gastrointestinal OTC Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal OTC Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal OTC Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal OTC Drugs Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal OTC Drugs by Type (2019-2025)
Figure 19. Sales Market Share of Gastrointestinal OTC Drugs by Type in 2023
Figure 20. Market Size Share of Gastrointestinal OTC Drugs by Type (2019-2025)
Figure 21. Market Size Market Share of Gastrointestinal OTC Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal OTC Drugs Market Share by Application
Figure 24. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2019-2025)
Figure 25. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal OTC Drugs Market Share by Application (2019-2025)
Figure 27. Global Gastrointestinal OTC Drugs Market Share by Application in 2023
Figure 28. Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2019-2025)
Figure 29. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2019-2025)
Figure 30. North America Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Gastrointestinal OTC Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Gastrointestinal OTC Drugs Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Gastrointestinal OTC Drugs Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Gastrointestinal OTC Drugs Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 50. South America Gastrointestinal OTC Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Gastrointestinal OTC Drugs Production Market Share by Region (2019-2025)
Figure 62. North America Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2019-2025)
Figure 65. China Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Gastrointestinal OTC Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Gastrointestinal OTC Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Gastrointestinal OTC Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Gastrointestinal OTC Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Gastrointestinal OTC Drugs Market Share Forecast by Application (2025-2032)
